Principles and Practice of Nephrocardiology
- 1st Edition - January 1, 2027
- Latest edition
- Editor: Parta Hatamizadeh
- Language: English
Principles and Practice of Nephrocardiology provides a comprehensive introduction to the interdisciplinary subspecialty of Nephrocardiology. The book includes detailed descri… Read more
Description
Description
Principles and Practice of Nephrocardiology provides a comprehensive introduction to the interdisciplinary subspecialty of Nephrocardiology. The book includes detailed descriptions, along with an in-depth exploration of its primary elements and topics. Coverage spans pathophysiology, epidemiology, prevention, diagnosis, prognosis, monitoring, therapy, risk factors, and the systemic diseases that involve both nephrology-related conditions and cardiovascular diseases. The book guides clinicians and general practitioners in multiple interdisciplinary specialties through diagnostic, preventive, and therapeutic approaches to a wide variety of patient populations. It also opens a myriad of new avenues for future research and guidance for approaching multiple medical topics.
Key features
Key features
- Introduces and defines the interdisciplinary subspecialty field of Nephrocardiology, with a delineation of its scope and in-depth exploration of its topics
- Includes novel viewpoints from leaders in the field on the interaction between the fields of nephrology and cardiovascular medicine
- Provides insights into pathophysiological mechanisms to help readers better understand the various aspects of the relationship between renal and cardiovascular disease
Readership
Readership
Clinicians in the fields of nephrology, cardiology, internal medicine, hospital medicine, preventive medicine, and primary care/general practice, as well as the researchers and scientists in the fields of nephrology, cardiovascular medicine, and physiology, Medical professionals in other fields of medicine, including physicians, physician assistants, nurse practitioners, medical students, nurses, nutritionists and physiologists
Table of contents
Table of contents
1. Introduction to Nephrocardiology
Section 1: Heart Failure and pulmonary hypertension
2. Introduction to cardiorenal syndrome
3. Assessment of volume status
4. Optimization of volume
5. Approach to the other aspects of cardiorenal syndrome besides hemodynamics
6. Combined Heart and Kidney Transplantation
7. Cardiogenic Shock
8. Nephrocardiologic aspects of pulmonary hypertension
Section 2: Ischemic Heart Disease
9. Epidemiology and pathophysiology of Ischemic heart disease in patients with Kidney Disease
10. Approach to Ischemic heart disease in the presence of Kidney Disease
11. Nephrology related conditions associated with Acute Coronary Syndrome
Section 3: Cardiac Arrhythmias
12. Atrial fibrillation
13. Sudden cardiac arrest
Section 4: Valvular Heart Diseases
14. Valvular heart disease associated with chronic Kidney disease
15. Nephrology related conditions associated with valvular heart diseases
Section 5: Congenital Heart Diseases
16. Mutual impact of kidney function and various congenital heart diseases
17. Electrolyte and acid base abnormalities associated with congenital heart diseases
Section 6: Systemic Hypertension
18. Overview of definition, diagnosis, prognosis, and management of hypertension
19. Hypertension and kidney diseases
20. Hypertension and cardiovascular diseases
21. Management of refractory hypertension
Section 7: Vascular Disorders
22. Endothelial dysfunction, the heart and the kidneys
23. Microangiopathy, the heart and the kidneys
24. Atherosclerotic vascular diseases in patients with and without CKD
25. Vascular calcification in CKD and uremia
26. Renovascular diseases
Section 8: Common Risk Factors in Nephrology and Cardiovascular Medicine
27. Diabetes Mellitus
28. Dyslipidemia
29. Hyperuricemia
30. Obesity and kidney
31. Obesity and cardiovascular system
32. Environmental pollutions
Section 9: Systemic Diseases that Impact Kidney and Cardiovascular System
Autoimmune Disease
33. Systemic Lupus Erythematosus
34. Systemic Sclerosis
35. Rheumatoid Arthritis
36. Antiphospholipid Syndrome
37. Psoriasis
Metabolic Disorders
38. Amyloidosis
39. Wilson disease
Ciliopathies
40. Autosomal Dominant Polycystic Kidney Disease
41. Autosomal Recessive Polycystic Kidney Disease
Other Ciliopathies
42. Medullary sponge kidney, Nephronophthisis, and medullary cystic Kidney disease
Other Hereditary Disorders
43. Fabry’s Disease
44. Alport Syndrome
45. Marfan Syndrome
Other Systemic Disorders that involve renal and cardiovascular systems
46. Sarcoidosis
47. Preeclampsia
Section 10: Chronic Kidney Disease and Cardiovascular System
48. Uremic toxins and intestinal microbiota, the kidney and the cardiovascular system
49. Mineral metabolism, the kidney and the cardiovascular system
50. Anemia, the kidney and the cardiovascular system
51. Inflammation and Oxidative Stress, the kidney and the cardiovascular system
Section 11: Cardiovascular interactions with nephrological interventions
52. Cardiovascular interactions of hemodialysis
53. Cardiovascular interactions of peritoneal dialysis
54. Cardiovascular interactions of kidney transplantation
55. Nephrology medications with cardiotoxicity and other cardiovascular impact
Section 12: Nephrological interactions with Cardiovascular interventions
56. Advanced heart failure devices and cardiac resynchronization therapy
57. Cardiac transplantation
58. Intravascular contrast material
59. Other nephrotoxic drugs and medications with nephrological interactions
60. Selection and Dosing of Cardiovascular Medications in the presence of nephrology related conditions
Section 13: Cardiovascular System and Electrolyte and Acid-Base Dysregulations
61. Abnormalities of potassium
62. Abnormalities of sodium
63. Abnormalities of magnesium
64. Acid-base dysregulations
Section 14: Other Connections between Nephrology and Cardiovascular Medicine
65. Nephrolithiasis and coronary artery disease
66. Renal glomerular diseases and cardiovascular diseases
Section 15: New Medications and State of the Art Methos and Technologies
67. New hypoglycemic agents
68. New mineralocorticoid receptor antagonists
69. Point of care ultrasound
Section 18: Future Horizon
70. Areas of further studies in nephrocardiology
71. The future of Nephrocardiology
Section 1: Heart Failure and pulmonary hypertension
2. Introduction to cardiorenal syndrome
3. Assessment of volume status
4. Optimization of volume
5. Approach to the other aspects of cardiorenal syndrome besides hemodynamics
6. Combined Heart and Kidney Transplantation
7. Cardiogenic Shock
8. Nephrocardiologic aspects of pulmonary hypertension
Section 2: Ischemic Heart Disease
9. Epidemiology and pathophysiology of Ischemic heart disease in patients with Kidney Disease
10. Approach to Ischemic heart disease in the presence of Kidney Disease
11. Nephrology related conditions associated with Acute Coronary Syndrome
Section 3: Cardiac Arrhythmias
12. Atrial fibrillation
13. Sudden cardiac arrest
Section 4: Valvular Heart Diseases
14. Valvular heart disease associated with chronic Kidney disease
15. Nephrology related conditions associated with valvular heart diseases
Section 5: Congenital Heart Diseases
16. Mutual impact of kidney function and various congenital heart diseases
17. Electrolyte and acid base abnormalities associated with congenital heart diseases
Section 6: Systemic Hypertension
18. Overview of definition, diagnosis, prognosis, and management of hypertension
19. Hypertension and kidney diseases
20. Hypertension and cardiovascular diseases
21. Management of refractory hypertension
Section 7: Vascular Disorders
22. Endothelial dysfunction, the heart and the kidneys
23. Microangiopathy, the heart and the kidneys
24. Atherosclerotic vascular diseases in patients with and without CKD
25. Vascular calcification in CKD and uremia
26. Renovascular diseases
Section 8: Common Risk Factors in Nephrology and Cardiovascular Medicine
27. Diabetes Mellitus
28. Dyslipidemia
29. Hyperuricemia
30. Obesity and kidney
31. Obesity and cardiovascular system
32. Environmental pollutions
Section 9: Systemic Diseases that Impact Kidney and Cardiovascular System
Autoimmune Disease
33. Systemic Lupus Erythematosus
34. Systemic Sclerosis
35. Rheumatoid Arthritis
36. Antiphospholipid Syndrome
37. Psoriasis
Metabolic Disorders
38. Amyloidosis
39. Wilson disease
Ciliopathies
40. Autosomal Dominant Polycystic Kidney Disease
41. Autosomal Recessive Polycystic Kidney Disease
Other Ciliopathies
42. Medullary sponge kidney, Nephronophthisis, and medullary cystic Kidney disease
Other Hereditary Disorders
43. Fabry’s Disease
44. Alport Syndrome
45. Marfan Syndrome
Other Systemic Disorders that involve renal and cardiovascular systems
46. Sarcoidosis
47. Preeclampsia
Section 10: Chronic Kidney Disease and Cardiovascular System
48. Uremic toxins and intestinal microbiota, the kidney and the cardiovascular system
49. Mineral metabolism, the kidney and the cardiovascular system
50. Anemia, the kidney and the cardiovascular system
51. Inflammation and Oxidative Stress, the kidney and the cardiovascular system
Section 11: Cardiovascular interactions with nephrological interventions
52. Cardiovascular interactions of hemodialysis
53. Cardiovascular interactions of peritoneal dialysis
54. Cardiovascular interactions of kidney transplantation
55. Nephrology medications with cardiotoxicity and other cardiovascular impact
Section 12: Nephrological interactions with Cardiovascular interventions
56. Advanced heart failure devices and cardiac resynchronization therapy
57. Cardiac transplantation
58. Intravascular contrast material
59. Other nephrotoxic drugs and medications with nephrological interactions
60. Selection and Dosing of Cardiovascular Medications in the presence of nephrology related conditions
Section 13: Cardiovascular System and Electrolyte and Acid-Base Dysregulations
61. Abnormalities of potassium
62. Abnormalities of sodium
63. Abnormalities of magnesium
64. Acid-base dysregulations
Section 14: Other Connections between Nephrology and Cardiovascular Medicine
65. Nephrolithiasis and coronary artery disease
66. Renal glomerular diseases and cardiovascular diseases
Section 15: New Medications and State of the Art Methos and Technologies
67. New hypoglycemic agents
68. New mineralocorticoid receptor antagonists
69. Point of care ultrasound
Section 18: Future Horizon
70. Areas of further studies in nephrocardiology
71. The future of Nephrocardiology
Product details
Product details
- Edition: 1
- Latest edition
- Published: January 1, 2027
- Language: English
About the editor
About the editor
PH
Parta Hatamizadeh
Parta Hatamizadeh, MD, MPH, is an assistant professor of medicine at University of Florida Health in the department of medicine, within the division of nephrology. He is board certified in internal medicine and nephrology. His clinical interests include nephrocardiology, cardiorenal syndrome, acute kidney injury and renal replacement therapy.
Affiliations and expertise
Assistant Professor of Medicine, Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA